Home > Gastroenterology > Stem cell-derived pancreatic cells may be alternative to islet transplants

Stem cell-derived pancreatic cells may be alternative to islet transplants


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 175
Journal
Cell Reports Medicine
Reuters Health - 25/01/2022 - An ongoing first-in-human trial suggests that pancreatic cells grown from stem cells can be safely implanted into patients with type 1 diabetes, and in some cases, begin producing insulin.  "I was surprised by how well the device implant and explant surgeries were tolerated by these patients, and to be able to measure human insulin in the blood in a third of (them)," Dr. A.M. James Shapiro of the University of Alberta told Reuters Health by email.  Dr. Shapiro led the team that developed the Edmonton Protocol, a process that allows transplantation of donated insulin-producing islet cells into the portal vein of people with type 1 d...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on